Saturday, October 31, 2026

Zynga Stock Bullish Momentum With A 4% Jump So Far On Wednesday

ViaNews Editorial Team

December 16, 2020

Zynga Stock Bullish Momentum With A 4% Jump So Far On Wednesday

Shares of Zynga rose 4% to $9.48 at 11:53 EST on Wednesday, after four successive sessions in a row of gains. The Nasdaq Stock Market is rising 0.2% to $12,619.70, after two sequential sessions in a row of gains. This seems, as yet, a somewhat positive trend exchanging session today.

Zynga's last close was $9.12, 12.76% below its 52-week high of $10.69.

Zynga's Sales

Zynga's sales growth is 56% for the present quarter and 55.1% for the next. The company's growth estimates for the present quarter and the next is 12.5% and 50%, respectively.

Zynga's Revenue

Year-on-year quarterly revenue growth grew by 45.8%, now sitting on 1.76B for the twelve trailing months.

Zynga's Stock Top and Bottom Yearly Value

Zynga's stock is valued at $9.48 at 11:53 EST, way below its 52-week high of $10.69 and way higher than its 52-week low of $5.65.

Zynga's Moving Average

Zynga's value is way higher than its 50-day moving average of $8.59 and above its 200-day moving average of $9.13.

Previous days news about Zynga

Zynga to put words with friends-style game on google nest devices in bid to lure nongamers. According to Bloomberg Quint on Mon Dec 14, "It's just the latest attempt by Zynga to broaden its appeal. ", "There's a joke inside the company, Kim said: If Zynga can find new customers by putting games on a refrigerator or toaster, that's just what it'll do."

Zynga stock gains after wells fargo upgrade. According to MarketWatch on Tue Dec 15, "Shares of Zynga Inc. are up 2.5% in Tuesday morning trading after Wells Fargo analyst Brian Fitzgerald upgraded the stock to overweight from equal weight. ", "Zynga's stock has declined 9.7% since Nov. 4, when Zynga last reported quarterly earnings. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com